clopidogrel has been researched along with fluvoxamine in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 6 (75.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Dansette, PM; Fontana, E; Poli, SM | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Dasgupta, K; Labos, C; Nedjar, H; Rahme, E; Turecki, G | 1 |
Andrade, C | 1 |
Al-Aieshy, F; Alcalai, R; Hirsh-Rokach, B; Lotan, A; Malmström, RE; Ritter, A; Shai, E; Spectre, G; Varon, D | 1 |
Bai, X; Chen, F; Fang, C; Han, M; Liu, M; Yang, G; Yang, Y; Zhao, J; Zhu, Q | 1 |
Della Pasqua, O; Duong, JK; Gross, AS; Nand, RA; Patel, A | 1 |
3 review(s) available for clopidogrel and fluvoxamine
Article | Year |
---|---|
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Terminology as Topic | 2005 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Drug interactions in the treatment of depression in patients with ischemic heart disease.
Topics: Aged; Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Aspirin; Clopidogrel; Comorbidity; Cytochrome P-450 CYP2C19; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Early Diagnosis; Fluoxetine; Fluvoxamine; Gastrointestinal Hemorrhage; Genotype; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Platelet Aggregation Inhibitors; Proportional Hazards Models; Risk Factors; Selective Serotonin Reuptake Inhibitors; Ticlopidine | 2012 |
1 trial(s) available for clopidogrel and fluvoxamine
Article | Year |
---|---|
Differential impact of selective serotonin reuptake inhibitors on platelet response to clopidogrel: a randomized, double-blind, crossover trial.
Topics: Adult; Citalopram; Clopidogrel; Cross-Over Studies; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Double-Blind Method; Drug Interactions; Fluvoxamine; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prodrugs; Selective Serotonin Reuptake Inhibitors; Ticlopidine; Young Adult | 2015 |
4 other study(ies) available for clopidogrel and fluvoxamine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction.
Topics: Adrenal Cortex Hormones; Age Factors; Aged; Anemia; Angioplasty; Anticoagulants; Antihypertensive Agents; Aspirin; Canada; Citalopram; Clopidogrel; Cohort Studies; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Heart Failure; Hemorrhage; Humans; Hypoglycemic Agents; Male; Middle Aged; Myocardial Infarction; Neoplasms; Paroxetine; Peptic Ulcer; Platelet Aggregation Inhibitors; Renal Insufficiency; Retrospective Studies; Risk; Risk Factors; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Ticlopidine | 2011 |
Effect of fluvoxamine on the pharmacokinetics and pharmacodynamics of clopidogrel in rats.
Topics: Animals; Antidepressive Agents, Second-Generation; Area Under Curve; Biotransformation; Carboxylic Acids; Clopidogrel; Drug Interactions; Fluvoxamine; Half-Life; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Ticlopidine | 2015 |
A physiologically based pharmacokinetic model of clopidogrel in populations of European and Japanese ancestry: An evaluation of CYP2C19 activity.
Topics: Clopidogrel; Cytochrome P-450 CYP2C19; Female; Fluvoxamine; Glucuronides; Humans; Japan; Kidney Diseases; Male | 2022 |